Saddle Brook, NJ — Everwell Health has completed its third strategic acquisition in as many months with the purchase of American River Nutrition (ARN), a U.S.-based manufacturer of science-backed healthy aging ingredients. The move enhances Everwell’s functional ingredient platform while adding specialized domestic manufacturing capabilities to produce high-potency bioactives.
The deal includes ARN’s proprietary annatto-based ingredients—most notably DeltaGold®, a tocopherol-free source of tocotrienols, and GG-Gold®, a form of geranylgeraniol (GG) critical for protein synthesis and hormone production. These patented, plant-derived compounds are known for their roles in supporting cardiovascular, metabolic, and mitochondrial health, as well as bone and muscle function. ARN’s ingredient DuoQuinol was excluded from the transaction and remains with its former parent company, Designs for Health.
Everwell will maintain operations at ARN’s state-of-the-art manufacturing site in Hadley, Massachusetts, which will serve as the company’s new primary Innovation Center. The facility, founded by Dr. Barrie Tan in 1998, includes proprietary solvent-free distillation technologies and an in-house lab for quality control and R&D. Everwell plans to invest further in the site as it expands its capabilities in producing nature-based, clinically supported ingredients.
“This acquisition reinforces our commitment to delivering scientifically substantiated ingredients that help consumers perform at their best,” said Steve Rosenman, CEO of Everwell Health. “With ARN’s unique portfolio and manufacturing expertise, we’re strengthening our position in key health areas such as cardiovascular and metabolic wellness, men’s health, and bone and muscle support.”
Designs for Health CEO Amardeep Kahlon expressed support for the deal, stating, “Everwell Health shares our dedication to science, quality, and innovation. We’re confident that ARN will thrive under its new leadership, allowing Designs for Health to sharpen our focus on clinical nutrition and integrative health through our core product lines.”
ARN will continue commercial and manufacturing operations under the name “American River Nutrition, an Everwell Health Company” through the end of 2025 before fully integrating into Everwell’s portfolio. Customers and partners are expected to benefit from the expanded innovation, resources, and supply chain capabilities brought by the transition.
